Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

Health and Quality of Life Outcomes
Klemens FheodoroffDavid M Simpson

Abstract

We evaluated quality of life among subjects with upper- and lower-limb spasticity who received escalating doses of incobotulinumtoxinA (total body doses up to 800 U) in the prospective, single-arm, dose-titration TOWER study. In this exploratory trial, subjects (N = 155; 18-80 years of age) with upper- and lower-limb spasticity due to cerebral causes who were deemed to require total body doses of up to 800 U incobotulinumtoxinA received three consecutive injection cycles of incobotulinumtoxinA (400, 600, and up to 800 U), each with 12 to 16 weeks' follow-up. QoL was assessed using the EuroQol 5-dimensions questionnaire, three-level (EQ-5D), before and 4 weeks post-injection in each injection cycle and at the end of injection cycle 3. The mean EQ-5D visual analog scale scores of 155 participants continuously improved from study baseline to 4 weeks post-injection in all injection cycles (mean [standard deviation] change 6.7 [14.1], 9.6 [16.3], and 8.6 [17.0] for injection cycles 1, 2, and 3, respectively; p < 0.0001 for all, paired sample t-test). In general, among those with a change in the EQ-5D rating of their condition, the proportion of subjects with 'improvement' was greater than that with 'worsening' for individual EQ-5D d...Continue Reading

References

Aug 9, 2002·The New England Journal of Medicine·Allison BrashearUNKNOWN Botox Post-Stroke Spasticity Study Group
Oct 19, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·A M O BakheitL Coxon
Feb 7, 2009·Journal of Rehabilitation Medicine·Jörg WisselNiko Tieranta
Aug 1, 2009·Clinical Neuropharmacology·Petr KanovskýSusanne Grafe
Dec 17, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D Dressler
Jun 24, 2010·Current Medical Research and Opinion·Ryuji KajiUNKNOWN GSK1358820 Spasticity Study Group
Jul 17, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A EsquenaziA B Ward
Apr 12, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M HerdmanX Badia
Oct 6, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Matthias HungerReiner Leidl
Dec 28, 2011·PM & R : the Journal of Injury, Function, and Rehabilitation·Quan V DoanElie P Elovic
Dec 12, 2012·Toxicon : Official Journal of the International Society on Toxinology·Alberto EsquenaziAnthony B Ward
Jul 18, 2014·Journal of Neural Transmission·Dirk DresslerChristoph Schrader
Apr 19, 2015·Health and Quality of Life Outcomes·Juntana Pattanaphesaj, Montarat Thavorncharoensap
Jul 24, 2015·Muscle & Nerve·Elie Paul ElovicChristina Marciniak
Sep 1, 2015·Lancet Neurology·Jean-Michel GraciesUNKNOWN International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group
Sep 30, 2015·Health and Quality of Life Outcomes·Patrick J GillardBrett Kissela
Jul 8, 2016·Disability and Rehabilitation·Michael BarnesKlemens Fheodoroff
Jul 10, 2016·Health Economics Review·Reinhard RychlikDirk Dressler
Mar 12, 2017·Neurology·Jörg WisselUNKNOWN TOWER study investigators

❮ Previous
Next ❯

Citations

Aug 18, 2020·Disability and Rehabilitation·Klemens FheodoroffJörg Wissel

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01603459

Software Mentioned

TOWER

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.